4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0002081460-26-000002
SVP, General Counsel sold 4,745 shares at $16.35 ($77,581)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cho Esther SVP, General Counsel | 2026-02-18 | Sale | −4,745 | $16.35 | $77,581 | 39,755 | D |
| Open-market sales · 4,745 sh · avg $16.35 · $77,581 | |||||||
Loading xslF345X05/form4-02202026_040204.xml…